Drooid Logo
Back to story perspectives

Full Breakdown

Lady Joan Branson’s Death Highlights Gaps in Hospital Blood-Clot Prevention

By Drooid · · How we work

Coroner’s Findings on Preventability

A senior coroner, Fiona Wilcox, concluded at Westminster Coroner’s Court that Lady Joan Branson’s death at age 80 was likely preventable. The 80-year-old died from a pulmonary embolism caused by deep-vein thrombosis (DVT) after being admitted to a hospital following a fall on Necker Island.

Medical Context and Hospital Decision-Making

DVT and subsequent pulmonary embolism are recognized complications for immobilized patients. Preventive anticoagulants such as enoxaparin are commonly used, though they carry bleeding risks that require a risk-benefit assessment. During the inquest, Dr. Basir Kunduzi, the admitting physician, testified that he did not complete a bleeding-risk assessment on the day of admission. He later reflected on the importance of communication among care teams. Emergency-medicine physician Dr. Jared Ross, who was not involved in the case, emphasized that “in the vast majority of cases, the benefits outweigh the risks” of blood-thinner use for hospitalized adults.

Official Reactions

A spokeswoman for Sir Richard Branson confirmed that the family will not comment further on the inquest. Branson himself posted on Instagram, describing his wife as the “shining star” of the family and expressing that “life will never be the same without her.” The hospital has not provided additional comment.

Verbatim Quotes

  • “I do find her death would have likely been prevented and the lack of anticoagulation did cause or contribute to her death probably,” — Fiona Wilcox, senior coroner
  • “In the vast majority of cases, the benefits outweigh the risks,” — Dr. Jared Ross, emergency-medicine physician
  • “Life will never be the same without her,” — Richard Branson, spokesperson

Implications for Hospital Practice

The coroner’s findings underscore the need for systematic bleeding-risk assessments and timely administration of prophylactic anticoagulants when indicated. Public-health agencies such as the Centers for Disease Control and Prevention and the National Heart, Lung, and Blood Institute advise prompt recognition of DVT symptoms and immediate medical attention for suspected pulmonary embolism, reinforcing the clinical priority highlighted by this case.